Biotech Startups

MLA Diagnostics develops a melanoma diagnostic test based on DNA methylation biomarkers to improve patient risk stratification and treatment decisions. The company serves oncology practices and pathology labs in the cancer diagnostics market.

1 investor

MNDL Bio combines scientific expertise with product engineering and commercial capabilities to bridge academic biotechnology discoveries and industrial-scale protein production applications.

1 investor

MOAB develops minibinders — small, stable, modular protein binders based on natural scaffolds — for use as new therapeutics. The company runs a data generation platform and AI models that design minibinder sequences by learning from biological function.

1 investor

Mobius Scientific develops treatments for age-related macular degeneration and other retinal diseases by targeting the root cause of vision loss. The company serves patients with progressive vision loss globally.

1 investor

MOC Biotechnologies builds hybrid 4D bioprinters and biomechatronic systems that print hard and soft tissue, organs, and cell scaffolds using hydrogels, polymers, and drugs for preclinical drug discovery and regenerative medicine. It serves research centers, universities, laboratories, and preclinical CROs, with applications including cancer research.

1 investor

ModernVivo is a software platform that automates literature review and analysis for in vivo study design in pharmaceutical research and preclinical development. It serves pharmaceutical companies, contract research organizations, academic labs, and institutional animal care committees by extracting study parameters from scientific literature to accelerate drug discovery timelines.

1 investor

Modulight develops a platform to treat severe neurological diseases through scientific innovation and clinical expertise.

1 investor

1 investor

Mojiabio produces Aliphane, a bio-based chemical ingredient used in adhesives for applications including wood furniture, footwear, flexible packaging, automotive, and EV batteries.

1 investor

Molab.ai develops technology for small molecule drug discovery. It was acquired by Cresset, a provider of software for digitizing drug discovery.

1 investor

Molagri develops biopesticides that target harmful insects through specific molecular mechanisms while protecting beneficial insects and the environment, and incorporates resistance modeling to maintain product efficacy over time.

1 investor

MolCube develops software for molecular modeling and simulation targeting pharmaceutical, biotechnology, and nanotechnology companies. The products enable complex biological and nanomaterial system simulation and computer-aided drug discovery through web-based or locally-installed solutions.

1 investor

A company that develops patented chemical formulations to control pest and vector populations through behavioral modification, serving applications in human health, agriculture, and livestock protection.

1 investor

Molecular Designs develops and sells research assays and molecular diagnostic panels designed to run on standard PCR platforms, serving research labs seeking cost-effective and efficient testing solutions. The company offers direct-to-customer purchasing with customization options and supply chain support.

1 investor

Molecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.

1 investor

MT develops cancer-specific molecular imaging agents (probes) targeting a common oncoprotein in the tumor microenvironment, intended for use with imaging modalities such as CT, PET, MRI, SPECT and ultrasound. The agents are aimed at early detection and diagnosis of aggressive tumors across multiple cancer types for clinical cancer management.

1 investor

Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets. Its products serve researchers in life sciences performing high-resolution imaging and expression profiling of cells and tissue samples.

1 investor

Moleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.

1 investor

Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.

1 investor

Molmir is an academic spinout developing technology to observe how molecules "move" and change shape based on liquid-liquid phase separation research, enabling previously undruggable dynamic molecules to be targeted in drug discovery. It focuses on diseases without established treatments such as ALS, Alzheimer's disease, cancer, and heart disease.

1 investor

Momentum Clinical Research (formerly PCRN) operates a network of 19 clinical research sites across Australia and New Zealand, conducting phase I to IV clinical trials across most therapeutic areas. It partners with pharmaceutical and biotech companies to run studies and recruits local participants as trial volunteers.

1 investor

Momentum TX develops therapeutics targeting the aging process to treat age-related conditions of the central and peripheral nervous systems, with a focus on neurodegeneration. It uses in silico, in vitro, and in vivo methods and proteomics data to identify drug targets that restore protein configurations altered in the aged brain.

1 investor

Monarch is a personal finance app for individuals, couples, and families that connects bank accounts, credit cards, loans, and investments into one view for budgeting, tracking spending, monitoring subscriptions, and setting savings goals. It works across web, iOS, and Android and lets users collaborate with a partner or financial advisor.

1 investor

Monarch Biosciences develops and commercializes medical device and biotechnology products based on Thin Film Nitinol technology.

1 investor